Pre-screening to identify adults who may be eligible for future metabolic and mental health opportunities.
Pre-screening Survey for Metabolic, Cardiovascular, Obesity, Mental Health, and Endocrine Trial Eligibility (DOVE-MET-COME-100)
Clindove Research LLC · NCT07106879
This prescreening will see if adults with metabolic conditions or mental health disorders qualify for upcoming clinical opportunities by collecting health history, basic tests, and a doctor interview.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 7000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Clindove Research LLC (other) |
| Locations | 1 site (Brooklyn, New York) |
| Trial ID | NCT07106879 on ClinicalTrials.gov |
What this trial studies
This single-site observational prescreening enrolls adults 18 and older to collect demographics, medical history, current symptoms, and basic health data including vital signs, urine drug screens, pregnancy tests when applicable, and blood samples. A physician oversees informed consent and conducts a one-on-one medical history review and eligibility interview. The study team may contact participants' current doctors or pharmacies to verify records when needed. No investigational treatments are given; data are used only to determine fit for future metabolic and psychiatric sub-studies.
Who should consider this trial
Good fit: Adults aged 18 and older with cardiovascular, metabolic, obesity-related, prediabetes, or mental health conditions who can give informed consent and comply with basic screening procedures are ideal candidates.
Not a fit: Pregnant or breastfeeding individuals, those with severe cognitive impairment or acute psychiatric emergencies, people with known drug or alcohol misuse, or those already enrolled in conflicting research are unlikely to benefit from this prescreening.
Why it matters
Potential benefit: If successful, this program could help people find and be referred to relevant future clinical opportunities more quickly.
How similar studies have performed: Other prescreening registries and pre-enrollment approaches have been used successfully to speed recruitment and match patients to suitable studies, so this is a commonly used method.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any participant of age 18 years and over * Who are willing to provide informed consent and participate in the pre-screening study and comply with study procedures. Exclusion Criteria: * Pregnant or breastfeeding individuals * Individuals having severe cognitive impairment or inability to provide informed consent * Individuals having acute psychiatric emergencies requiring immediate intervention/hospitalization * Individuals who are currently participating in another research study that conflicts with pre-screening data collection * Individuals having known history of drug/alcohol misuse * Individuals having medical conditions that, in the investigator's opinion, could compromise the integrity of the screening process or pose significant risks to the participant's health.
Where this trial is running
Brooklyn, New York
- Clindove Research LLC — Brooklyn, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Nelly Cohen, MD — Clindove Research LLC
- Study coordinator: Nelly Cohen, MD
- Email: study@clindoveresearch.com
- Phone: 516-518-3239
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cardiovascular Diseases, Metabolic Syndrome, Obesity, Prediabetes, Mental Health Disorders, Endocrine Dysfunction, Type 2 Diabetes Mellitus, Chronic Kidney Disease